FDA Inspection
Cdymax (India) Pharma Private LimitedCdymax (India) Pharma Private Limited – FDA Inspection, Apr 25, 2025
Record Details
This FDA Inspection record concerns Cdymax (India) Pharma Private Limited, with an inspection on April 25, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a643d37d-6f70-40f5-a91d-a549b5742e4b
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1271325
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Cdymax (India) Pharma Private Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 31, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 17, 2019 | Not classified | Office of Inspections and Investigations | |
| August 14, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cdymax (India) Pharma Private Limited
- FDA Inspection 1118683 - 2020-01-31
- FDA Inspection 1093684 - 2019-05-17
- FDA Inspection 940635 - 2015-08-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.